🔎 Trials Near Me

Home › Prostate Cancer › Texas › San Antonio

Prostate Cancer clinical trials in San Antonio, TX

27 studies for Prostate Cancer are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

RecruitingPhase 1
  • South Texas Accelerated Research Therapeutics (START), San Antonio
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Audie L Murphy VA Hospital, San Antonio
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

RecruitingPhase 1
  • South Texas Accelerated Research Therapeutics, LLC (START), San Antonio
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06095089

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

RecruitingPhase 1/2
  • START, San Antonio
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07288359

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RecruitingPhase 3
  • Brooke Army Medical Center, Fort Sam Houston · 4 mi away
Ages 18 and older · Men · Updated Oct 23, 2026 · NCT05946213

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

RecruitingPhase 1
  • USA Clinical Trials, San Antonio
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07103018

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

RecruitingPhase 1
  • START San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06582017

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06239194

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

RecruitingPhase 3
  • Urology San Antonio, San Antonio
Ages 18 to 100 · Men · Updated Oct 15, 2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

RecruitingPhase 3
  • Research Site, San Antonio
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT06952803

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RecruitingPhase 3
  • Audie L Murphy VA Hospital, San Antonio
Ages 18 and older · Men · Updated Oct 8, 2026 · NCT03678025

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • South Texas Accelerated Research Therapeutics, LLC, San Antonio
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

RecruitingPhase 1/2
  • Research Site, San Antonio
Ages 18 to 130 · All sexes · Updated Oct 5, 2026 · NCT05417594

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RecruitingPhase 1/2
  • New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07719361

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

RecruitingPhase 3
  • The Urology Place, San Antonio
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005

Prostate Active Surveillance Study

RecruitingObservational study
  • University of Texas Health Science Center, San Antonio, San Antonio
Ages 21 and older · Men · Updated Sep 2, 2026 · NCT00756665

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

RecruitingObservational study
  • The Urology Place, Inc., San Antonio
All ages · Men · Updated Aug 18, 2026 · NCT07455058

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · Men · Updated Aug 10, 2026 · NCT06067841

IDOV-Immune for Advanced Solid Tumors

RecruitingPhase 1
  • South Texas Accelerated Research Therapeutics, San Antonio
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06910657

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • NEXT Oncology San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Apr 7, 2026 · NCT07424547

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

RecruitingPhase 1/2
  • START San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07145255

Customized TULSA-PRO Ablation Registry

RecruitingObservational study
  • Urology Place, San Antonio
Ages 18 and older · Men · Updated Nov 6, 2024 · NCT05001477

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in San Antonio

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.